{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:27:24Z","timestamp":1782487644542,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02020-5","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:57:07Z","timestamp":1742961427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the efficacy of totally implantable venous access port in breast cancer patients undergoing chemotherapy"],"prefix":"10.1007","volume":"16","author":[{"given":"Yujuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"2020_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.sopen.2023.07.016","volume":"15","author":"P Prihantono","year":"2023","unstructured":"Prihantono P, Faruk M. Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution. Surg Open Sci. 2023;15:19\u201325. https:\/\/doi.org\/10.1016\/j.sopen.2023.07.016.","journal-title":"Surg Open Sci"},{"key":"2020_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbii.2023.100003","author":"S Ryu","year":"2023","unstructured":"Ryu S, Liao N, McDonough DJ, Gao Z. Chinese breast cancer survivors\u2019 functional fitness, biomarkers, and physical activity determinants and behaviors: a descriptive study. Brain Behav Immun Integrat. 2023. https:\/\/doi.org\/10.1016\/j.bbii.2023.100003.","journal-title":"Brain Behav Immun Integrat"},{"issue":"3","key":"2020_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jncc.2021.07.003","volume":"1","author":"F Ma","year":"2021","unstructured":"Ma F, Wu J, Fu L, Li A, Lan B, Chen K, Di J, Jiang Y, Li J, Li N, Li Y, Liu P, Lu J, Niu L, Peng W, Shen S, Shi J, Sun Q, Tong Z, Wang J, Wang Y, Wang S, Xie Y, Ying J, Zhang J, Zhang K, Zhang Z, Zheng Y, Zhu Q, Xu B. Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women. J Natl Cancer Center. 2021;1(3):97\u2013100. https:\/\/doi.org\/10.1016\/j.jncc.2021.07.003.","journal-title":"J Natl Cancer Center"},{"key":"2020_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100002","author":"K Venetis","year":"2023","unstructured":"Venetis K, Cursano G, Pescia C, D\u2019Ercole M, Porta FM, Blanco MC, Frascarelli C, Ivanova M, Guerini Rocco E, Fusco N. Liquid biopsy: cell-free DNA based analysis in breast cancer. J Liquid Biopsy. 2023. https:\/\/doi.org\/10.1016\/j.jlb.2023.100002.","journal-title":"J Liquid Biopsy"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.breast.2023.01.003","volume":"67","author":"E Roberts","year":"2023","unstructured":"Roberts E, Howell S, Evans DG. Polygenic risk scores and breast cancer risk prediction. Breast. 2023;67:71\u20137. https:\/\/doi.org\/10.1016\/j.breast.2023.01.003.","journal-title":"Breast"},{"key":"2020_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.107028","author":"AM Gregoire","year":"2022","unstructured":"Gregoire AM, VoPham T, Laden F, Yarosh R, O\u2019Brien KM, Sandler DP, White AJ. Residential ultraviolet radiation and breast cancer risk in a large prospective cohort. Environ Int. 2022. https:\/\/doi.org\/10.1016\/j.envint.2021.107028.","journal-title":"Environ Int"},{"key":"2020_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2023.100517","author":"A Arian","year":"2023","unstructured":"Arian A, Ghazanfari Hashemi M, Talebi V, AhmadiNejad N, Eslami B, Sedighi N, Omranipour R. Abbreviated breast MRI for evaluating breast cancer before initiation of neoadjuvant chemotherapy: a cross-sectional study. Eur J Radiol Open. 2023. https:\/\/doi.org\/10.1016\/j.ejro.2023.100517.","journal-title":"Eur J Radiol Open"},{"issue":"10","key":"2020_CR8","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.jsps.2022.07.011","volume":"30","author":"SA Dewidar","year":"2022","unstructured":"Dewidar SA, Hamdy O, Eltantawy A, El-Mesery M, El Gayar AM, Soliman MM. Effect of concomitant use of pitavastatin with neoadjuvant chemotherapy protocols in breast cancer patients: a randomized controlled clinical trial. Saudi Pharm J. 2022;30(10):1486\u201396. https:\/\/doi.org\/10.1016\/j.jsps.2022.07.011.","journal-title":"Saudi Pharm J"},{"issue":"9","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.asjsur.2020.05.023","volume":"43","author":"P Zhang","year":"2020","unstructured":"Zhang P, Mo X, Du J, Fan C. Clinical application of totally implantable venous access ports for patients with breast cancer. Asian J Surg. 2020;43(9):944\u20135. https:\/\/doi.org\/10.1016\/j.asjsur.2020.05.023.","journal-title":"Asian J Surg"},{"issue":"9","key":"2020_CR10","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1111\/jth.14930","volume":"18","author":"M Jiang","year":"2020","unstructured":"Jiang M, Li CL, Pan CQ, Cui XW, Dietrich CF. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: a systematic review and meta-analysis. J Thromb Haemost. 2020;18(9):2253\u201373. https:\/\/doi.org\/10.1111\/jth.14930.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"e0255473","DOI":"10.1371\/journal.pone.0255473","volume":"16","author":"B Liu","year":"2021","unstructured":"Liu B, Wu Z, Lin C, Li L, Kuang X. Applicability of TIVAP versus PICC in non-hematological malignancies patients: a meta-analysis and systematic review. PLoS ONE. 2021;16(8):e0255473. https:\/\/doi.org\/10.1371\/journal.pone.0255473.","journal-title":"PLoS ONE"},{"issue":"3","key":"2020_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijnss.2021.05.005","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhao R, Jiang N, Shi Y, Wang Q, Sheng Y. A retrospective observational study on maintenance and complications of totally implantable venous access ports in 563 patients: prolonged versus short flushing intervals. Int J Nurs Sci. 2021;8(3):252\u20136. https:\/\/doi.org\/10.1016\/j.ijnss.2021.05.005.","journal-title":"Int J Nurs Sci"},{"issue":"02","key":"2020_CR13","doi-asserted-by":"publisher","first-page":"079","DOI":"10.1055\/s-0043-57247","volume":"10","author":"H Singh","year":"2023","unstructured":"Singh H. Role of molecular targeted therapeutic drugs in treatment of breast cancer: a review article. Global Med Genet. 2023;10(02):079\u201386. https:\/\/doi.org\/10.1055\/s-0043-57247.","journal-title":"Global Med Genet"},{"key":"2020_CR14","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2017.20.4.333","author":"D Li","year":"2017","unstructured":"Li D, Mai V, Gerke T, Pinney SM, Yaghjyan L. Interactions of family history of breast cancer with radiotherapy in relation to the risk of breast cancer recurrence. J Breast Cancer. 2017. https:\/\/doi.org\/10.4048\/jbc.2017.20.4.333.","journal-title":"J Breast Cancer"},{"issue":"1","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4999\/uhod.15649","volume":"25","author":"NB Duman","year":"2015","unstructured":"Duman NB. The risk level of breast cancer and breast cancer awareness among the Turkish women aged 65 years and older. Int J Hematol Oncol. 2015;25(1):60\u20139. https:\/\/doi.org\/10.4999\/uhod.15649.","journal-title":"Int J Hematol Oncol"},{"issue":"6","key":"2020_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.31557\/apjcp.2021.22.6.1775","volume":"22","author":"H Syarif","year":"2021","unstructured":"Syarif H, Waluyo A, Afiyanti Y. Cognitive perception among post-chemotherapy, non-chemotherapy breast cancer survivors and non-cancer. Asian Pacific J Cancer Prev. 2021;22(6):1775\u201380. https:\/\/doi.org\/10.31557\/apjcp.2021.22.6.1775.","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"5","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.addr.2008.10.003","volume":"61","author":"S Marsh","year":"2009","unstructured":"Marsh S, Liu G. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy. Adv Drug Deliv Rev. 2009;61(5):381\u20137. https:\/\/doi.org\/10.1016\/j.addr.2008.10.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"2020_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30120-7","author":"P McGale","year":"2018","unstructured":"McGale P, Dodwell D, Taylor C, Gray R. Neoadjuvant chemotherapy for early breast cancer\u2014Author\u2019s reply. Lancet Oncol. 2018. https:\/\/doi.org\/10.1016\/s1470-2045(18)30120-7.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2020_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.surg.2019.01.001","volume":"165","author":"SJ Pommier","year":"2019","unstructured":"Pommier SJ, Morgan RE, Limbach KE, Jackson CM, Naik AM, Peckham JL, Muller PJ, Condron ME, Jameson NE, Pommier RF. Surgical resection of breast cancers: molecular analysis of cancer stem cells in residual disease. Surgery. 2019;165(5):1008\u201313. https:\/\/doi.org\/10.1016\/j.surg.2019.01.001.","journal-title":"Surgery"},{"key":"2020_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1100427","author":"SA Adham","year":"2022","unstructured":"Adham SA, Szewczuk MR, Mraiche F, Petricoin E. Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.1100427.","journal-title":"Front Oncol"},{"key":"2020_CR21","doi-asserted-by":"publisher","first-page":"153303382211210","DOI":"10.1177\/15330338221121086","volume":"21","author":"H Zhang","year":"2022","unstructured":"Zhang H, Tang S, Biskup E, et al. Long-term Survival after diverse therapeutic modalities in malignant phyllodes tumors of the breast. Technol Cancer Res Treat. 2022;21:15330338221121086. https:\/\/doi.org\/10.1177\/15330338221121086.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"2020_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3892\/ol.2022.13405","volume":"24","author":"S Tang","year":"2022","unstructured":"Tang S, Zhang Y, Lin X, et al. CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer. Oncol Lett. 2022;24(2):285. https:\/\/doi.org\/10.3892\/ol.2022.13405.","journal-title":"Oncol Lett"},{"issue":"10","key":"2020_CR23","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s00520-010-0984-9","volume":"19","author":"R Biffi","year":"2011","unstructured":"Biffi R, Orsi F, Pozzi S, et al. No impact of central venous insertion site on oncology patients\u2019 quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer. 2011;19(10):1573\u201380. https:\/\/doi.org\/10.1007\/s00520-010-0984-9.","journal-title":"Support Care Cancer"},{"issue":"2","key":"2020_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1177\/0300060518808167","volume":"47","author":"S Bademler","year":"2019","unstructured":"Bademler S, \u00dc\u00e7\u00fcnc\u00fc M, Y\u0131ld\u0131r\u0131m \u0130, Karanl\u0131k H. Risk factors for complications in cancer patients with totally implantable access ports: a retrospective study and review of the literature. J Int Med Res. 2019;47(2):702\u20139. https:\/\/doi.org\/10.1177\/0300060518808167.","journal-title":"J Int Med Res"},{"issue":"4","key":"2020_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/pbc.22286","volume":"54","author":"SH Nam","year":"2010","unstructured":"Nam SH, Kim DY, Kim SC, Kim IK. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer. 2010;54(4):546\u201351. https:\/\/doi.org\/10.1002\/pbc.22286.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2020_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost. 2017;117(2):219\u201330. https:\/\/doi.org\/10.1160\/TH16-08-0615.","journal-title":"Thromb Haemost"},{"issue":"5","key":"2020_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2020;38(5):496\u2013520. https:\/\/doi.org\/10.1200\/JCO.19.01461.","journal-title":"J Clin Oncol"},{"key":"2020_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2022.104341","volume":"135","author":"J Fu","year":"2022","unstructured":"Fu J, Cai W, Zeng B, et al. Development and validation of a predictive model for peripherally inserted central catheter-related thrombosis in breast cancer patients based on artificial neural network: a prospective cohort study. Int J Nurs Stud. 2022;135: 104341. https:\/\/doi.org\/10.1016\/j.ijnurstu.2022.104341.","journal-title":"Int J Nurs Stud"},{"issue":"12","key":"2020_CR29","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00270-023-03583-y","volume":"46","author":"T Suzuki","year":"2023","unstructured":"Suzuki T, Michimoto K, Hasumi J, et al. Silver-mixed port reduces venous access port related infection rate compared to non-silver-mixed port: a single-center retrospective analysis. Cardiovasc Intervent Radiol. 2023;46(12):1696\u2013702. https:\/\/doi.org\/10.1007\/s00270-023-03583-y.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2020_CR30","doi-asserted-by":"publisher","first-page":"1241780","DOI":"10.3389\/fsurg.2023.1241780","volume":"10","author":"M Zhang","year":"2023","unstructured":"Zhang M, Lyu X, Wang J, et al. Value of a novel Y-Z magnetic totally implantable venous access port in improving the success rate of one-time needle insertion. Front Surg. 2023;10:1241780. https:\/\/doi.org\/10.3389\/fsurg.2023.1241780.","journal-title":"Front Surg"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02020-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:57:09Z","timestamp":1742961429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02020-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study complied with the principles of medical ethics of Zhangzhou Affiliated Hospital Fujian Medical University. Ethical approval for this study was obtained from Zhangzhou Affiliated Hospital Fujian Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients agreed to this study and signed the relevant documents. All participants or, if participants are under 18, from a parent and\/or legal guardian.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"383"}}